University of Chicago
Chicago, Il
Steven J. Chmura MD, PhD is the director of Clinical and Translational Research for Radiation Oncology at the University of Chicago for over a decade. He is also the Scientific Director of the Clinical Cancer Trials Office at the University of Chicago Comprehensive Cancer Center. He has been actively involved in both the clinical implementation of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). His main interests and research focus on translational and clinical trial development in the developmental therapeutics space. Dr. Chmura is a leader in the NCI cooperative groups and has led to the first international oligometastatic trials through NRG Oncology examining the safety of treating oligometastatic patients (NRG BR001) as well as the ongoing Phase II/III trial examining potential improvements to progression-free survival and overall survival of SBRT in oligometastatic breast cancer patients (NRG BR002). Dr. Chmuras work in radio-immunology has also translated into multiple investigator-sponsored trials along with the now accruing NCI-sponsored (A091605) trial randomizing the role of SBRT combined with pembrolizumab in advanced Merkel cell carcinoma; such integration of ablative radiotherapy and immunotherapy along with advancing the search for biomarkers is currently Dr. Chmuras focus.
Disclosures:
SS 01 - Breast Cancer 1: Clinical Trials
Sunday, September 29, 2024
8:00 AM – 9:00 AM ET